Gastric Cancer Clinical Trial Results

Browse clinical trials for Gastric Cancer by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable
  Phase 1/2 · Hoffmann-La Roche · Terminated · Aug 3, 2026
• Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso
  Phase 1 · National Cancer Institute (NCI) · Active, not recruiting · Jun 8, 2025
• Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Jun 25, 2024
• Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric o
  Phase 2 · University of Southern California · Completed · Jul 30, 2026
• Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gast
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Jul 8, 2025
• Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or L
  Phase 3 · National Cancer Institute (NCI) · Active, not recruiting · Apr 28, 2016
• Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (
  Phase 2 · ECOG-ACRIN Cancer Research Group · Active, not recruiting · Apr 8, 2026
• NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
  Phase 1/2 · NuCana plc · Terminated · Jul 23, 2026
• Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma
  Phase 2 · University of California, Irvine · Completed · Aug 11, 2025
• A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subje
  Phase 3 · Astellas Pharma Global Development, Inc. · Active, not recruiting · Jan 27, 2025
• A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2
  Phase 2 · Hoffmann-La Roche · Active, not recruiting · Oct 17, 2024
• A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
  Phase 1/2 · AstraZeneca · Active, not recruiting · Oct 13, 2023
• Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or
  Phase 1 · National Cancer Institute (NCI) · Active, not recruiting · Jul 13, 2026
• EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
  N/A · Johns Hopkins University · Completed · Jul 6, 2026
• A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cance
  Phase 1/2 · AstraZeneca · Active, not recruiting · Jun 13, 2025

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials